FBXL8 and colorectal carcinoma: CRC was further divided into nmCRC and mCRC according to the presence or absence of liver metastasis, and FBXL8 was found to be highly expressed in mCRC, suggesting that FBXL8 may be associated with poor prognosis in CRC patients.